Dr. Anne Croy is a professor in the Department of Biomedical Sciences at Queen’s University. She also holds a Canada Research Chair (Tier 1) in Reproduction, Development, and Sexual Function, which is reflective of the outstanding contributions she has made to the field of reproductive biology. While her current research interests lie with conditions that affect human pregnancy, such as preeclampsia, she boasts a long career of research in immunology as well. Currently, Dr. Croy is hanging up her lab coat as she bids farewell to over 30 years in research and heads into retirement.
Oncologist Lu You’s research group at Sichuan University injected a patient with CRISPR modified cells on November 15, marking the first time CRISPR gene-editing has been tested in a human. The team delivered modified cells into a patient suffering from aggressive lung cancer as part of their clinical trial at the West China Hospital in Chengdu. The study stands as a key milestone in the CRISPR revolution, which began in 2013 with the discovery of CRISPR’s genome editing potential.